ULILEDLIMAB
UNII 3OX1DBR75G

Substance Identification & Data

This profile provides standardized clinical and technical data for Uliledlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3OX1DBR75G.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2378407-27-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3OX1DBR75G

CAS Registry Number

2378407-27-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ULILEDLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C159168

National Cancer Institute reference terminology for clinical and research data.

INN ID

11597

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-99

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Uliledlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ULILEDLIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G1 (300-ALANINE), ANTI-(HUMAN CD73 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL TJ004309 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL TJ004309 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS NT5E (5'-NUCLEOTIDASE ECTO, 5' NUCLEOTIDASE, NT5, EN, ENT NTE, CALJA, CD73)), MONOCLONAL ANTIBODY; GAMMA1 HEAVY CHAIN (1-450) (VH (HOMO SAPIENS IGHV4-38-2*01 (87.6%) -(IGHD) -IGHJ6*01 (100%)) CDR-IMGT (9.7.13) (26-34.52-58.97-109) (1-120) -HOMO SAPIENS IGHG1*03V, G1M3>G1M17, NG1M1 (CH1 R>K 120 (217) (121-218), HINGE 1-15 (219-233), CH2 N84.4>A (300) (234-343), CH3 E12 (359), M14 (361) (344-448), CHS(449-450)) (121-450)), (223-213')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-215') (V-KAPPA (MUS MUSCULUS IGKV4-72*01 (81.1%) -IGKJ1*01 (90.9%) L124>V (103)/HOMO SAPIENS IGKV3-11*01 (77.9%) -IGKJ4*01 (100%)) CDR-IMGT (5.3.9) (26-31.59-51.88-96) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (152), V101 (190) (107'-213')); DIMER (229-229'':232-232'')-BISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 CELL LINE, NON-GLYCOSYLATED

ULILEDLIMAB [INN]

ULILEDLIMAB [USAN]

ULILEDLIMAB [WHO-DD]